Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feigenbaum

Showing results (721-730 of 761) with videos related to

Pageof 77
Sort By:
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Orphanet Journal of Rare Diseases|February 5, 2016
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort studyMaria D Karaceper, Pranesh Chakraborty, Doug Coyle, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Human Mutation|October 13, 2018
Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase GeneDiane B Zastrow, Heather Baudet, Wei Shen, et al.
Immunity|December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signaturePawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
Circulation Research|February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trialVasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Molecular Genetics and Metabolism|March 2, 2010
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders ConsortiumJennifer Seminara, Mendel Tuchman, Lauren Krivitzky, et al.
Science (New York, N.Y.)|September 18, 2010
IDH2 mutations in patients with D-2-hydroxyglutaric aciduriaMartijn Kranendijk, Eduard A Struys, Emile van Schaftingen, et al.
Molecular Genetics and Metabolism|October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratioM Mokhtarani, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism|September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disordersM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 77

Showing results (721-730 of 761) with videos related to

Sort By:
Pageof 77
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Orphanet Journal of Rare Diseases|February 5, 2016
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort studyMaria D Karaceper, Pranesh Chakraborty, Doug Coyle, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Human Mutation|October 13, 2018
Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase GeneDiane B Zastrow, Heather Baudet, Wei Shen, et al.
Immunity|December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signaturePawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
Circulation Research|February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trialVasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Molecular Genetics and Metabolism|March 2, 2010
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders ConsortiumJennifer Seminara, Mendel Tuchman, Lauren Krivitzky, et al.
Science (New York, N.Y.)|September 18, 2010
IDH2 mutations in patients with D-2-hydroxyglutaric aciduriaMartijn Kranendijk, Eduard A Struys, Emile van Schaftingen, et al.
Molecular Genetics and Metabolism|October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratioM Mokhtarani, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism|September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disordersM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 77